187. Kabuki syndrome Clinical trials / Disease details

Clinical trials : 3 / Drugs : 8 - (DrugBank : 2) / Drug target genes : 3 - Drug target pathways : 15

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04722315 (ClinicalTrials.gov)	April 1, 2021	24/11/2020	Study of Modified Atkins Diet in Kabuki Syndrome	Pilot Clinical Trial of Modified Atkins Diet for Kabuki Syndrome	Kabuki Syndrome	Dietary Supplement: Modified Atkins diet	Hugo W. Moser Research Institute at Kennedy Krieger, Inc.	NULL	Recruiting	18 Years	N/A	All	15	Early Phase 1	United States
2	EUCTR2012-000432-26-NL (EUCTR)	26/09/2012	27/03/2012	Prospective study on the metabolic and linear growth effects of growh hormone treatment in children with Kabuki Syndrome	Prospective study on the metabolic and linear growth effects of growh hormone treatment in children with Kabuki Syndrome - Metabolic effects of Growth Hormone	Kabuki Syndrome (KS, OMIM 147920) with a mutation in MLL2 gene. ;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]	Trade Name: Genotropin Product Name: Genotropin INN or Proposed INN: SOMATROPIN Other descriptive name: recombinant DNA-derived human growth hormone	Maastricht University Medical Centre	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Netherlands
3	NCT00723580 (ClinicalTrials.gov)	May 2008	24/7/2008	Actigraphic Analysis of Treatment Response	Actigraphic Analysis of Treatment Response in a Six Year Old Girl With Kabuki Syndrome	Sleep Disorders, Circadian Rhythm;Insomnia;Psychomotor Agitation	Drug: risperidone	Child Psychopharmacology Institute	NULL	Completed	2 Years	10 Years	Female	1	N/A	United States